Correlation Between Sarepta Therapeutics and Vericel Corp
Can any of the company-specific risk be diversified away by investing in both Sarepta Therapeutics and Vericel Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarepta Therapeutics and Vericel Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sarepta Therapeutics and Vericel Corp Ord, you can compare the effects of market volatilities on Sarepta Therapeutics and Vericel Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarepta Therapeutics with a short position of Vericel Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarepta Therapeutics and Vericel Corp.
Diversification Opportunities for Sarepta Therapeutics and Vericel Corp
-0.21 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Sarepta and Vericel is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Sarepta Therapeutics and Vericel Corp Ord in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vericel Corp Ord and Sarepta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarepta Therapeutics are associated (or correlated) with Vericel Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vericel Corp Ord has no effect on the direction of Sarepta Therapeutics i.e., Sarepta Therapeutics and Vericel Corp go up and down completely randomly.
Pair Corralation between Sarepta Therapeutics and Vericel Corp
Given the investment horizon of 90 days Sarepta Therapeutics is expected to generate 1.75 times more return on investment than Vericel Corp. However, Sarepta Therapeutics is 1.75 times more volatile than Vericel Corp Ord. It trades about 0.14 of its potential returns per unit of risk. Vericel Corp Ord is currently generating about 0.07 per unit of risk. If you would invest 11,248 in Sarepta Therapeutics on September 14, 2024 and sell it today you would earn a total of 1,199 from holding Sarepta Therapeutics or generate 10.66% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sarepta Therapeutics vs. Vericel Corp Ord
Performance |
| Timeline |
| Sarepta Therapeutics |
| Vericel Corp Ord |
Sarepta Therapeutics and Vericel Corp Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sarepta Therapeutics and Vericel Corp
The main advantage of trading using opposite Sarepta Therapeutics and Vericel Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarepta Therapeutics position performs unexpectedly, Vericel Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vericel Corp will offset losses from the drop in Vericel Corp's long position.| Sarepta Therapeutics vs. Puma Biotechnology | Sarepta Therapeutics vs. Iovance Biotherapeutics | Sarepta Therapeutics vs. Day One Biopharmaceuticals | Sarepta Therapeutics vs. Inozyme Pharma |
| Vericel Corp vs. Puma Biotechnology | Vericel Corp vs. Iovance Biotherapeutics | Vericel Corp vs. Day One Biopharmaceuticals | Vericel Corp vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |